• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在新冠疫情背景下严重急性呼吸综合征冠状病毒的流行病学变化

Changing epidemiology of SARS-CoV in the context of COVID-19 pandemic.

作者信息

Bhattacharya S, Basu P, Poddar S

机构信息

Department of Zoology, Asutosh College, University of Calcutta, India.

Tomas Bata University in Zlin, Czech Republic.

出版信息

J Prev Med Hyg. 2020 Jul 4;61(2):E130-E136. doi: 10.15167/2421-4248/jpmh2020.61.2.1541. eCollection 2020 Jun.

DOI:10.15167/2421-4248/jpmh2020.61.2.1541
PMID:32802995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7419125/
Abstract

SARS-CoV-2 is a new form of β-coronavirus that has been recently discovered and is responsible for COVID 19 pandemic. The earliest infection can be traced back to Wuhan, China. From there it has spread all over the world. Keeping in view the above perspective, an attempt is made in order to find out the epidemiological pattern of COVID 19 pandemic, if any, in different geo-climatological regions of the world in terms of case incidence and mortality. This study is also an endeavor to review and analyze the gradual changes of the genetic makeup of SARS-CoV from evolutionary and epidemiological perspectives. The raw data of COVID-19 cases and death incidences were collected from the World Health Organization (WHO) website from the time period: 1 April to 6 April, 2020. The data that are utilized here for general and Case fatality rate (CFR) based analysis. Western pacific region, European region and Americas have the greatest number of infected cases (P < 0.001); whereas deaths have been found to be significantly higher in Europe (P < 0.001). Total number of confirmed cases and deaths in south-east Asia are comparatively lower (P < 0.001). Case fatality rate (CFR) has also found significant for European region. SARS-CoV-2 is considered to be a strain of SARS-CoV that has a high rate of pathogenicity and transmissibility. Result indicated that the European region has been affected mostly for both cases and death incidences. The novel mutations in SARS-CoV-2 possibly increase the virus infectivity. Genetic heterogeneity of this virus within the human population might originate as the representatives of naturally selected virus quasispecies. In this context, the presence of the asymptomatic individuals could be a significant concern for SARS-CoV-2 epidemiology. Further studies are required to understand its genetic evolution and epidemiological significance.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种新发现的β冠状病毒,是导致2019冠状病毒病大流行的病原体。最早的感染病例可追溯到中国武汉,随后疫情蔓延至全球。基于上述背景,本文旨在研究2019冠状病毒病大流行在世界不同地理气候区域的流行病学模式,包括病例发生率和死亡率。本研究还从进化和流行病学角度对SARS-CoV基因组成的逐渐变化进行了综述和分析。2019冠状病毒病病例和死亡发生率的原始数据收集自世界卫生组织(WHO)网站,时间范围为2020年4月1日至4月6日。这些数据用于基于总体和病死率(CFR)的分析。西太平洋地区、欧洲地区和美洲地区的感染病例数最多(P<0.001);而欧洲的死亡人数显著更高(P<0.001)。东南亚地区的确诊病例和死亡总数相对较低(P<0.001)。欧洲地区的病死率也有显著差异。SARS-CoV-2被认为是SARS-CoV的一个毒株,具有高致病性和高传播性。结果表明,欧洲地区在病例和死亡发生率方面受影响最大。SARS-CoV-2中的新型突变可能会增加病毒的传染性。该病毒在人群中的基因异质性可能源于自然选择的病毒准种的代表。在这种情况下,无症状感染者的存在可能是SARS-CoV-2流行病学的一个重大问题。需要进一步研究以了解其基因进化和流行病学意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ca/7419125/59e7d2a40579/jpmh-2020-02-e130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ca/7419125/8d9bf52288c9/jpmh-2020-02-e130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ca/7419125/59e7d2a40579/jpmh-2020-02-e130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ca/7419125/8d9bf52288c9/jpmh-2020-02-e130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ca/7419125/59e7d2a40579/jpmh-2020-02-e130-g002.jpg

相似文献

1
Changing epidemiology of SARS-CoV in the context of COVID-19 pandemic.在新冠疫情背景下严重急性呼吸综合征冠状病毒的流行病学变化
J Prev Med Hyg. 2020 Jul 4;61(2):E130-E136. doi: 10.15167/2421-4248/jpmh2020.61.2.1541. eCollection 2020 Jun.
2
The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health.持续的 SARS-CoV-2 疫情威胁及其对未来全球公共卫生的影响。
Curr Opin Virol. 2020 Feb;40:37-40. doi: 10.1016/j.coviro.2020.05.010. Epub 2020 Jun 4.
3
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
4
New SARS-like virus in China triggers alarm.中国出现类似非典的新型病毒引发警报。
Science. 2020 Jan 17;367(6475):234-235. doi: 10.1126/science.367.6475.234.
5
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.新出现的冠状病毒:首例SARS、第二例MERS和第三例SARS-CoV-2:新型冠状病毒肺炎的流行病学新进展
Infez Med. 2020 Jun 1;28(suppl 1):6-17.
6
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
7
Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.社区获得性呼吸道病毒流行期间严重急性呼吸综合征冠状病毒 2 的流行病学。
J Infect Dis. 2020 Sep 14;222(8):1270-1279. doi: 10.1093/infdis/jiaa464.
8
Novel coronavirus pandemic: A clinical overview.新型冠状病毒大流行:临床概述。
S Afr Fam Pract (2004). 2020 Jun 26;62(1):e1-e5. doi: 10.4102/safp.v62i1.5123.
9
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
10
Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020.2020 年 1 月至 2 月中国武汉市 2019 年冠状病毒病(COVID-19)传播潜力和毒力的早期流行病学评估。
BMC Med. 2020 Jul 15;18(1):217. doi: 10.1186/s12916-020-01691-x.

引用本文的文献

1
Prevalence of SARS-CoV-2 antibodies at the University hospital Heidelberg and correlation with SARS-CoV-2 incidence.海德堡大学医院中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体的流行情况及其与SARS-CoV-2发病率的相关性。
Heliyon. 2024 Nov 13;10(22):e40282. doi: 10.1016/j.heliyon.2024.e40282. eCollection 2024 Nov 30.
2
Genomic analysis of three SARS-CoV-2 waves in west Sumatra: Evolutionary dynamics and variant clustering.西苏门答腊岛新冠病毒(SARS-CoV-2)三个流行阶段的基因组分析:进化动态与变异聚类
Heliyon. 2024 Jul 9;10(14):e34365. doi: 10.1016/j.heliyon.2024.e34365. eCollection 2024 Jul 30.
3
The impact of comorbidity status in COVID-19 vaccines effectiveness before and after SARS-CoV-2 omicron variant in northeastern Mexico: a retrospective multi-hospital study.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
3
Stability of SARS-CoV-2 in different environmental conditions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在不同环境条件下的稳定性
墨西哥东北部奥密克戎变异株出现前后,合并症对 COVID-19 疫苗有效性的影响:一项回顾性多医院研究。
Front Public Health. 2024 Jun 12;12:1402527. doi: 10.3389/fpubh.2024.1402527. eCollection 2024.
4
Vaccination status and disease severity of COVID-19 in different phases of the pandemic.疫苗接种状况和大流行不同阶段 COVID-19 疾病严重程度。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2353491. doi: 10.1080/21645515.2024.2353491. Epub 2024 Jun 4.
5
Advancing Perioperative Neurocognitive Health: A Critical Review of Predictive Tools, Diagnostic Methods, and Interventional Strategies.推进围手术期神经认知健康:对预测工具、诊断方法和干预策略的批判性综述
Cureus. 2024 May 1;16(5):e59436. doi: 10.7759/cureus.59436. eCollection 2024 May.
6
Addressing the COVID-19 Pandemic in an Iranian Sample: Health Beliefs and Respondent Characteristics Associated with Preventive Behaviors.应对伊朗样本中的 COVID-19 大流行:与预防行为相关的健康信念和应答者特征。
J Prev Med Hyg. 2022 Apr 26;63(1):E12-E18. doi: 10.15167/2421-4248/jpmh2022.63.1.2063. eCollection 2022 Mar.
7
Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain.新冠病毒 Sars-CoV-2 对肺感染与大脑关联的细胞和分子作用。
Front Immunol. 2021 Aug 13;12:730088. doi: 10.3389/fimmu.2021.730088. eCollection 2021.
Lancet Microbe. 2020 May;1(1):e10. doi: 10.1016/S2666-5247(20)30003-3. Epub 2020 Apr 2.
4
Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.冠状病毒感染:流行病学、临床及免疫学特征与假说
Cell Stress. 2020 Mar 2;4(4):66-75. doi: 10.15698/cst2020.04.216.
5
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
6
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.雪貂、猫、狗和其他驯养动物对 SARS-CoV-2 的易感性。
Science. 2020 May 29;368(6494):1016-1020. doi: 10.1126/science.abb7015. Epub 2020 Apr 8.
7
COVID-19: what has been learned and to be learned about the novel coronavirus disease.新型冠状病毒病(COVID-19):对新型冠状病毒疾病的认识与探索。
Int J Biol Sci. 2020 Mar 15;16(10):1753-1766. doi: 10.7150/ijbs.45134. eCollection 2020.
8
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.中国浙江 36 例 2019 冠状病毒病(COVID-19)患儿的临床和流行病学特征:一项观察性队列研究。
Lancet Infect Dis. 2020 Jun;20(6):689-696. doi: 10.1016/S1473-3099(20)30198-5. Epub 2020 Mar 25.
9
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
10
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.